Alliance for Regenerative Medicine (ARM) | 2020 Cell & Gene Therapies State of the Industry
Sheila Mikhail – CEO, President, Co-Founder
Next Generation Gene and Cell Technologies
January 13, 2020
Shelia Mikhail, CEO, AskBio
Laurence Cooper, CEO, Ziopharm
Timothy Miller, President & Chief Scientific Officer, Abeona Therapeutics
ARM, the international advocacy organization representing the cell and gene therapy and broader regenerative medicine sector, announced its 2020 Cell & Gene Therapies State of the Industry briefing will take place January 13, 2020 in San Francisco, held in conjunction with Biotech Showcase™ 2020. ARM’s State of the Industry briefing is the largest cell and gene therapy-focused annual event taking place during the week of the 2020 J.P. Morgan Healthcare Conference. The event will be broadcast live via streaming webcast available on ARM’s website.